The British Journal of Cardiology

This site is intended for UK healthcare professionals

 
BJC_tv_logo_white
Sign in

Featured Videos #1

Cardiac inflammation: the fire within

Federica Marelli-Berg takes a look at some common and not-so-common causes of myocarditis, and the clinical manifestations cardiologists should consider.

ESC Congress 2024 highlights – A UK perspective: What’s new in the latest ESC guideline update?

Dr Paul Foley and Prof Terry McCormack share the key changes in the new ESC guidance on atrial fibrillation, hypertension and arterial disease.

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

ESC Congress 2024 highlights – A UK perspective: New evidence on cardiovascular medical care

Dr Sarah Birkhoelzer and Dr Aaron Henry discuss hot topics and late-breaking abstracts from across the congress.

AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations. The remainder of the programme has remained under the full editorial control of the British Journal of Cardiology.

Transcatheter cardiac valves: An update in 2024

Jon Byrne and Madalina Garbi explore the latest guidelines and current practice around transcatheter valve interventions (including aortic valve implantation (TAVI), mitral regurgitation management and tricuspid valve repair) – which patients are suitable for these interventions, and how do they compare to traditional surgical approaches?

Cardiorenal changes in later life

This webinar has been sponsored by A Menarini Pharmaceuticals Ireland and A. Menarini Farmaceutica Internazionale SRL who have had no input into the topics discussed or selection of speakers.

Masterclass: Treating dyslipidaemia – special populations

In this masterclass, Alison Pottle and Jai Cegla provide discuss screening for familial hypercholesterolaemia (FH), treatment advances in dyslipidaemia, the role of lipid apheresis in specific populations and the importance of patient education.

Key highlights from Heart Failure 2024 – Annual congress of the Heart Failure Association of the ESC

Professor Paul Kalra summarises key findings presented at the 2024 Heart Failure Association ESC meeting in Lisbon. He discusses the new data on hypertrophic cardiomyopathy, heart failure with reduced ejection fraction, and challenges in diagnosis and treatment optimisation. He also explores the early benefits of sodium-glucose co-transporter 2 inhibitors and evidence-based treatments for heart failure with preserved ejection fraction.

Harmonising the guidelines: making sense of lipid treatment advice

Watch Terry McCormack and Rani Khatib discuss the updates to lipid management guidelines to reduce the risk of cardiovascular disease and implications for clinical practice. They will provide an overview of which patients should be treated, outline the current lipid-lowering targets and introduce the range of suitable treatments.
 

Thanks for your feedback. Please note that by including your email address, you are giving permission for us to contact you by email to help resolve any issues.